Trial Profile
Effect of rituximab used as a either single agent or as a part of regimen in real world patients chronic lymphocytic leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Bendamustine; Chlorambucil; Cyclophosphamide; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 02 Jun 2015 New trial record